Journal
NUCLEIC ACIDS RESEARCH
Volume 44, Issue 18, Pages 8655-8670Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkw522
Keywords
-
Categories
Funding
- Canton de Geneve
- Swiss National Science Foundation
- Fondation Medic
Ask authors/readers for more resources
The estrogen receptor alpha (ER alpha) is a transcription factor that can be directly activated by estrogen or indirectly by other signaling pathways. We previously reported that activation of the unliganded ER alpha by cAMP is mediated by phosphorylation of the transcriptional coactivator CARM1 by protein kinase A (PKA), allowing CARM1 to bind ER alpha directly. This being insufficient by itself to activate ER alpha, we looked for additional factors and identified the histone H3 demethylase LSD1 as a substrate of PKA and an important mediator of this signaling crosstalk as well as of the response to estrogen. Surprisingly, ER alpha engages not only LSD1, but its partners of the CoREST corepressor complex and the molecular chaperone Hsp90. The recruitment of Hsp90 to promote ER alpha transcriptional activity runs against the steroid receptor paradigm and suggests that it might be involved as an assembly factor or scaffold. In a breast cancer cell line, which is resistant to the anti-estrogen tamoxifen because of constitutively activated PKA, some interactions are constitutive and drug combinations partially rescue tamoxifen sensitivity. In ER alpha-positive breast cancer patients, high expression of the genes encoding some of these factors correlates with poor prognosis. Thus, these mechanisms might contribute to ER alpha-driven breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available